Biomnis (Legionellosis analysis division) Overview
- Status
-
Acquired/Merged
- Employees
-
891
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Biomnis (Legionellosis analysis division) General Information
Description
Provider of testing and research services for legionellosis diseases. The company's research works and services include a pneumonia-type illness called Legionnaires' disease and a mild flu-like illness called Pontiac fever.
Contact Information
Corporate Office
- 17/19 Avenue Tony Garnier
- 69007 Lyon
- France
Corporate Office
- 17/19 Avenue Tony Garnier
- 69007 Lyon
- France
Biomnis (Legionellosis analysis division) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biomnis (Legionellosis analysis division) Signals
Biomnis (Legionellosis analysis division) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Biomnis (Legionellosis analysis division) FAQs
-
Where is Biomnis (Legionellosis analysis division) headquartered?
Biomnis (Legionellosis analysis division) is headquartered in Lyon, France.
-
What is the size of Biomnis (Legionellosis analysis division)?
Biomnis (Legionellosis analysis division) has 891 total employees.
-
What industry is Biomnis (Legionellosis analysis division) in?
Biomnis (Legionellosis analysis division)’s primary industry is Laboratory Services (Healthcare).
-
Is Biomnis (Legionellosis analysis division) a private or public company?
Biomnis (Legionellosis analysis division) is a Private company.
-
What is Biomnis (Legionellosis analysis division)’s current revenue?
The current revenue for Biomnis (Legionellosis analysis division) is .
-
Who are Biomnis (Legionellosis analysis division)’s investors?
Biomnis has invested in Biomnis (Legionellosis analysis division).
-
When was Biomnis (Legionellosis analysis division) acquired?
Biomnis (Legionellosis analysis division) was acquired on 01-Jan-2010.
-
Who acquired Biomnis (Legionellosis analysis division)?
Biomnis (Legionellosis analysis division) was acquired by Groupe Alpa.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process